Audentes investing $109M in gene therapy manufacturing facility with 200 jobs 0 19.02.2020 17:13 Fiercepharma.com With a gene therapy nearing the finish line and $3 billion in hand from its buyout by Astellas, biotech Audentes is ready to start work on its $109 million gene therapy manufacturing facility that will employ 200. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
